Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

e-Poster Display Session

283P - Descriptive epidemiology of head and neck cancer in Niger: First results from the National Cancer Registry

Date

22 Nov 2020

Session

e-Poster Display Session

Topics

Cancer Care Equity Principles and Health Economics

Tumour Site

Head and Neck Cancers

Presenters

Salamatou Mamoudou Garba

Citation

Annals of Oncology (2020) 31 (suppl_6): S1347-S1354. 10.1016/annonc/annonc360

Authors

S. Mamoudou Garba1, H. Hami2, H. Mahamadou Zaki3, A. Soulaymani2, H. Nouhou3, A. Mokhtari2, A. Quyou2

Author affiliations

  • 1 Laboratory Of Pathological Anatomy And Cytology, Faculty Of Health Sciences, Abdou Moumouni University, 10896 - Niamey/NE
  • 2 Laboratory Of Genetics And Biometry, Faculty Of Science, Ibn Tofail University, Kenitra/MA
  • 3 Laboratory Of Pathological Anatomy And Cytology, Faculty Of Health Sciences, Abdou Moumouni University, Niamey/NE

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 283P

Background

Worldwide, there are approximately 560 000 new cases diagnosed with head and neck cancer and 300 000 deaths each year. In developing countries including Sub-Saharan Africa, head and neck cancer is rare compared to other cancers. The aims of this study are to estimate the incidence and determine the epidemiological characteristics of head and neck cancer in the population of Niger.

Methods

This is a descriptive retrospective study of head and neck cancer cases, reported to the Niger Cancer Registry in the period 1992-2009. Head and neck cancer includes the following: lip, tongue, mouth (floor, palate and other), salivary glands, tonsils, pharynx (oro-, naso- and hypopharynx), larynx, nose, ear, head and neck not otherwise specified.

Results

In 1992-2009, there were 344 cases diagnosed with head and neck cancer in Niger, which was 4.89% of all cases of cancer reported during this period, with a male-female ratio of 1.49. The incidence rate of head and neck cancer was 2.34 cases per 100 000 persons. Oral cancer was the most common cancer (27.6%), followed by laryngeal and salivary glands cancers (13.1%) and tonsil cancer (10.2%). The mean age at diagnosis of the patients was 42.11±18.24 years. The commonest histological type was squamous cell carcinoma in 27.1% of cases. We registered 11 deaths, with a fatality rate of 3.19%.

Conclusions

Although the incidence rates for head and neck cancers are lower, these cancers include a diverse group of uncommon tumors that frequently are aggressive. Because of the seriousness of cancer in Niger; the health authorities should pay more attention to this pathology through efficient fight strategies.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

The authors.

Funding

Has not received any funding.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.